An Update on Randomized Clinical Trials in Metastatic Colorectal Carcinoma
Author:
Publisher
Elsevier BV
Subject
Oncology,Surgery
Reference69 articles.
1. Comparison of oral capecitabine versus intravenous fluorouracil plus leucovorin as first-line treatment in 605 patients with metastatic colorectal cancer: results of a randomized phase III study;Hoff;J Clin Oncol,2001
2. Oral capecitabine compared with intravenous fluorouracil plus leucovorin in patients with metastatic colorectal cancer: results of a large phase III study;Van Cutsem;J Clin Oncol,2001
3. Randomized trial comparing monthly low-dose leucovorin and fluorouracil bolus with bimonthly high-dose leucovorin and fluorouracil bolus plus continuous infusion for advanced colorectal cancer: a French intergroup study;de Gramont;J Clin Oncol,1997
4. Efficacy of capecitabine versus 5-fluorouracil in colorectal and gastric cancers: a meta-analysis of individual data from 6171 patients;Cassidy;Ann Oncol,2011
5. Randomised phase-II trial of CAPIRI (capecitabine, irinotecan) plus bevacizumab vs FOLFIRI (folinic acid, 5-fluorouracil, irinotecan) plus bevacizumab as first-line treatment of patients with unresectable/metastatic colorectal cancer (mCRC);Souglakos;Br J Cancer,2012
Cited by 24 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Zebrafish Avatar-test forecasts clinical response to chemotherapy in patients with colorectal cancer;Nature Communications;2024-06-05
2. PACMIDS: Patient-Centered, AI-Enabled, Molecular-Informed Data Fabric for Clinical Treatment Decision Support;AI in Precision Oncology;2024-04-01
3. The rational modulation of autophagy sensitizes colorectal cancer cells to 5‐fluouracil and oxaliplatin;Journal of Cellular Biochemistry;2024-01-15
4. Randomized Trial of FOLFOX 4 and FOLFIRI in The Treatment of Advance Colorectal Cancer;Pakistan Journal of Health Sciences;2023-11-30
5. Model‐based prediction of progression‐free survival for combination therapies in oncology;CPT: Pharmacometrics & Systems Pharmacology;2023-06-16
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3